Total planned funding: $1,394,879,077
Clear active filters
Private Contractor
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Tanzania | $252,096,514 |
| Nigeria | $190,944,019 |
| Zambia | $168,528,499 |
| Kenya | $126,475,522 |
| Uganda | $102,455,280 |
| Mozambique | $100,841,676 |
| South Africa | $84,356,609 |
| Ethiopia | $65,765,945 |
| Rwanda | $53,780,863 |
| Zimbabwe | $49,195,680 |
| Côte d'Ivoire | $36,378,290 |
| Haiti | $29,401,849 |
| Eswatini | $25,377,597 |
| Namibia | $23,129,515 |
| Democratic Republic of the Congo | $18,586,742 |
| Botswana | $14,296,607 |
| Malawi | $11,587,780 |
| Vietnam | $10,620,674 |
| Lesotho | $4,164,432 |
| Guyana | $3,885,000 |
| Ukraine | $3,752,913 |
| Burundi | $3,605,329 |
| Ghana | $3,598,467 |
| Cameroon | $2,858,624 |
| South Sudan | $2,089,229 |
| Russia | $1,850,000 |
| Angola | $1,850,000 |
| India | $1,689,272 |
| Cambodia | $1,000,000 |
| China | $716,150 |
Organizational Types
| Private Contractor | $1,394,879,077 |
Program Areas
| Treatment | $844,037,289 |
| Care | $188,975,162 |
| Governance and Systems | $179,137,117 |
| Prevention | $129,170,288 |
| Testing | $49,092,145 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $617,033,446 |
| HTXS: Treatment: Adult Treatment | $208,380,667 |
| OHSS: Health Systems Strengthening | $95,336,255 |
| HBHC: Care: Adult Care and Support | $79,382,606 |
| HKID: Care: Orphans and Vulnerable Children | $67,572,665 |
| HLAB: Laboratory Infrastructure | $54,824,886 |
| HVCT: Testing: HIV Testing and Counseling | $49,092,145 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $39,977,012 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $34,652,042 |
| HVSI: Strategic Information | $28,975,976 |
| HVTB: Care: TB/HIV | $25,747,109 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $21,285,040 |
| PDTX: Treatment: Pediatric Treatment | $18,623,176 |
| PDCS: Care: Pediatric Care and Support | $16,272,782 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $15,971,301 |
| HMIN: Biomedical Prevention: Injection Safety | $12,448,202 |
| HMBL: Biomedical Prevention: Blood Safety | $3,152,109 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $1,684,582 |
Top Partner Programs
Chemonics International:
$649,553,446
View countries
Deloitte Consulting Limited:
$40,810,693
View countries